DrugId:  1
1. Name:  Streptococcus pneumoniae type 4 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 4 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 4 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  2
1. Name:  Streptococcus pneumoniae type 19f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 19f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 19f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  3
1. Name:  Streptococcus pneumoniae type 23f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 23f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 23f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  4
1. Name:  Streptococcus pneumoniae type 12f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 12f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 12f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  5
1. Name:  Streptococcus pneumoniae type 2 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 2 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  6
1. Name:  Streptococcus pneumoniae type 3 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 3 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 3 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  7
1. Name:  Streptococcus pneumoniae type 15b capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 15b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 15b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  8
1. Name:  Streptococcus pneumoniae type 22f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 22f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 22f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  9
1. Name:  Streptococcus pneumoniae type 6b capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  10
1. Name:  Streptococcus pneumoniae type 18c capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 18c capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 18c of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  11
1. Name:  Streptococcus pneumoniae type 9v capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 9v capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9v of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  12
1. Name:  Streptococcus pneumoniae type 14 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 14 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 14 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  13
1. Name:  Streptococcus pneumoniae type 7f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 7f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  14
1. Name:  Streptococcus pneumoniae type 8 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 8 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 8 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  15
1. Name:  Streptococcus pneumoniae type 11a capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 11a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 11a of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  16
1. Name:  Streptococcus pneumoniae type 17f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 17f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 17f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  17
1. Name:  Streptococcus pneumoniae type 20 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 20 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  18
1. Name:  Streptococcus pneumoniae type 1 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 1 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 1 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  19
1. Name:  Streptococcus pneumoniae type 5 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 5 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 5 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  20
1. Name:  Streptococcus pneumoniae type 9n capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 9n capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9n of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  21
1. Name:  Streptococcus pneumoniae type 10a capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 10a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 10a of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  22
1. Name:  Streptococcus pneumoniae type 19a capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 19a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 19a of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  23
1. Name:  Streptococcus pneumoniae type 33f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 33f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 33f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  24
1. Name:  Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen
2. Groups:  Approved
3. Description:  Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains N. meningitis serogroup W-135 capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
4. Indication:  Not Available
DrugId:  25
1. Name:  Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
2. Groups:  Approved
3. Description:  Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine contains N. meningitis serogroup c capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
4. Indication:  Not Available
